Top Glove Corporation Bhd. (TGLVY)
USD 1.06
(0.0%)
USD 1.06
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.25 Billion MYR | -59.49% |
| 2022 | 5.57 Billion MYR | -65.94% |
| 2021 | 16.36 Billion MYR | 126.07% |
| 2020 | 7.23 Billion MYR | 50.74% |
| 2019 | 4.8 Billion MYR | 13.92% |
| 2018 | 4.21 Billion MYR | 23.62% |
| 2017 | 3.4 Billion MYR | 18.03% |
| 2016 | 2.88 Billion MYR | 15.06% |
| 2015 | 2.51 Billion MYR | 10.33% |
| 2014 | 2.27 Billion MYR | -1.64% |
| 2013 | 2.31 Billion MYR | -0.05% |
| 2012 | 2.31 Billion MYR | 12.68% |
| 2011 | 2.05 Billion MYR | -1.23% |
| 2010 | 2.07 Billion MYR | 35.99% |
| 2009 | 1.52 Billion MYR | 10.97% |
| 2008 | 1.37 Billion MYR | 12.14% |
| 2007 | 1.22 Billion MYR | 23.79% |
| 2006 | 992.61 Million MYR | 54.65% |
| 2005 | 641.82 Million MYR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 636.87 Million MYR | 15.73% |
| 2024 Q1 | 493.45 Million MYR | 3.65% |
| 2024 Q2 | 550.33 Million MYR | 11.53% |
| 2023 Q3 | 530.62 Million MYR | -14.14% |
| 2023 Q2 | 618 Million MYR | -2.3% |
| 2023 FY | 2.25 Billion MYR | -59.49% |
| 2023 Q1 | 632.53 Million MYR | -41.12% |
| 2023 Q4 | 476.06 Million MYR | -10.28% |
| 2022 Q4 | 1.07 Billion MYR | -26.65% |
| 2022 Q2 | 1.44 Billion MYR | -8.51% |
| 2022 Q1 | 1.58 Billion MYR | -23.65% |
| 2022 FY | 5.57 Billion MYR | -65.94% |
| 2022 Q3 | 1.46 Billion MYR | 1.06% |
| 2021 Q4 | 2.07 Billion MYR | -50.16% |
| 2021 Q3 | 4.16 Billion MYR | -22.42% |
| 2021 Q2 | 5.36 Billion MYR | 12.74% |
| 2021 Q1 | 4.75 Billion MYR | 53.02% |
| 2021 FY | 16.36 Billion MYR | 126.07% |
| 2020 Q3 | 1.68 Billion MYR | 37.29% |
| 2020 Q4 | 3.11 Billion MYR | 84.22% |
| 2020 Q1 | 1.2 Billion MYR | 1.69% |
| 2020 FY | 7.23 Billion MYR | 50.74% |
| 2020 Q2 | 1.22 Billion MYR | 1.71% |
| 2019 Q1 | 1.26 Billion MYR | 3.66% |
| 2019 Q2 | 1.15 Billion MYR | -8.08% |
| 2019 Q3 | 1.19 Billion MYR | 2.61% |
| 2019 FY | 4.8 Billion MYR | 13.92% |
| 2019 Q4 | 1.18 Billion MYR | -0.11% |
| 2018 Q3 | 1.1 Billion MYR | 14.83% |
| 2018 Q4 | 1.21 Billion MYR | 10.61% |
| 2018 Q2 | 958.44 Million MYR | 2.17% |
| 2018 Q1 | 938.11 Million MYR | 3.96% |
| 2018 FY | 4.21 Billion MYR | 23.62% |
| 2017 Q1 | 785.58 Million MYR | 8.79% |
| 2017 FY | 3.4 Billion MYR | 18.03% |
| 2017 Q4 | 902.41 Million MYR | 3.77% |
| 2017 Q3 | 869.64 Million MYR | 2.13% |
| 2017 Q2 | 851.53 Million MYR | 8.4% |
| 2016 FY | 2.88 Billion MYR | 15.06% |
| 2016 Q1 | 800.27 Million MYR | 12.8% |
| 2016 Q3 | 672.27 Million MYR | -3.11% |
| 2016 Q4 | 722.11 Million MYR | 7.41% |
| 2016 Q2 | 693.85 Million MYR | -13.3% |
| 2015 Q4 | 709.44 Million MYR | 7.3% |
| 2015 Q3 | 661.19 Million MYR | 15.54% |
| 2015 Q2 | 572.24 Million MYR | 0.81% |
| 2015 FY | 2.51 Billion MYR | 10.33% |
| 2015 Q1 | 567.62 Million MYR | -1.98% |
| 2014 Q3 | 573.99 Million MYR | 4.69% |
| 2014 Q2 | 548.27 Million MYR | -4.48% |
| 2014 Q1 | 573.98 Million MYR | 4.71% |
| 2014 FY | 2.27 Billion MYR | -1.64% |
| 2014 Q4 | 579.11 Million MYR | 0.89% |
| 2013 FY | 2.31 Billion MYR | -0.05% |
| 2013 Q2 | 576.41 Million MYR | -1.4% |
| 2013 Q4 | 548.15 Million MYR | -9.26% |
| 2013 Q1 | 584.57 Million MYR | -3.75% |
| 2013 Q3 | 604.08 Million MYR | 4.8% |
| 2012 Q3 | 603.29 Million MYR | 9.89% |
| 2012 FY | 2.31 Billion MYR | 12.68% |
| 2012 Q1 | 554.84 Million MYR | 2.4% |
| 2012 Q2 | 548.99 Million MYR | -1.05% |
| 2012 Q4 | 607.32 Million MYR | 0.67% |
| 2011 Q3 | 535.36 Million MYR | 10.34% |
| 2011 Q4 | 541.83 Million MYR | 1.21% |
| 2011 Q2 | 485.2 Million MYR | 0.0% |
| 2011 FY | 2.05 Billion MYR | -1.23% |
| 2010 FY | 2.07 Billion MYR | 35.99% |
| 2009 FY | 1.52 Billion MYR | 10.97% |
| 2008 FY | 1.37 Billion MYR | 12.14% |
| 2007 FY | 1.22 Billion MYR | 23.79% |
| 2006 FY | 992.61 Million MYR | 54.65% |
| 2005 FY | 641.82 Million MYR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | -70626.598% |
| Ansell Limited | 1.61 Billion USD | -39.395% |
| Ansell Limited | 1.61 Billion USD | -39.395% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 184.64 Million USD | -1122.449% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -1671234.641% |
| Psykey, Inc. | 419.29 Thousand USD | -538232.073% |
| ConvaTec Group Plc | 2.19 Billion USD | -2.881% |
| ConvaTec Group Plc | 2.14 Billion USD | -5.359% |
| Encision Inc. | 6.58 Million USD | -34173.633% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 1.82 Million USD | -123588.426% |
| LifePoint, Inc. | -18.5 Thousand USD | 12201294.595% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | -33031.088% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | -292286.14% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | -228776.011% |
| Reflect Scientific, Inc. | 1.08 Million USD | -208872.147% |
| SmileDirectClub, Inc. | 470.74 Million USD | -379.502% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | -20.603% |
| SheerVision, Inc. | 3.49 Million USD | -64402.957% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | -162724.12% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | -302844.867% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -2164414.83% |